Skip to main content
Healthcare

STAT+: Highly anticipated Moderna-Merck melanoma cancer vaccine data arrived early

STAT+: Highly anticipated Moderna-Merck melanoma cancer vaccine data arrived early

Feed excerpt — reported by STAT News

In data released at ESMO, the Moderna-Merck personalized mRNA cancer vaccine reduced recurrence-free survival and the time until distant metastasis occurred.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.